Multicationic Bis(guanidiniocarbonylpyrrole) Receptors
FULL PAPER
CH), 5.02 (s, 4H; benzyl-CH2), 6.77 (s, 4H; pyrrole-CH), 7.27–7.34 (m,
12H; aryl-CH, NH), 8.07 (s, 2H; NH), 8.40 (s, 2H; NH), 8.55 (s, 2H;
guanidine-NH), 9.32 (s, 2H; guanidine-NH), 10.91 (brs, 2H; guanidine-
NH), 11.29 ppm (brs, 2H; pyrrole-NH); 13C NMR (100 MHz,
[D6]DMSO, 258C): d=27.8 (Boc-CH3), 38.3 (CH2), 40.7 (CH2), 55.2
(CH), 65.6 (benzyl-CH2), 112.1 (pyrrole-CH), 127.7 (aryl-CH), 128.3
(aryl-CH), 136.8 (Cq), 155.8 (Cq), 158.4 (Cq), 160.3 (Cq), 170.0 ppm
(Cq); IR (ATR): n˜ =1720 (m), 1627 (m), 1532 (m), 1239 (s), 1146 (s),
1051 (m), 842 cmꢀ1 (s); MALDI MS: m/z: 1057.1 [M+H]+, 957.1
[MHꢀBoc]+, 857.1 [M+Hꢀ2Boc]+.
Dicationic compound 1: The protected compound 6 (100 mg, 0.10 mmol)
was dissolved in TFA (3 mL) and stirred at room temperature for 2 h.
The TFA was evaporated, the obtained residue was dissolved in aqueous
solution of HCl (5%, 1.5 mL) and lyophilized to yield a colorless solid
(37 mg, 0.04 mmol, 40%). Rf =0.24 (SiO2, ethyl acetate/methanol 9:1+
NEt3 (0.1%); m.p. 2438C; 1H NMR (400 MHz, [D6]DMSO, 258C): d=
3.11 (s, 4H; CH2), 3.56 (s, 4H; CH2), 4.16–4.21 (m, 2H; CH), 4.97–5.06
(m, 4H; benzyl-CH2), 6.85–6.87 (m, 2H; pyrrole-CH), 7.27–7.36 (m,
14H; aryl-CH, pyrrole-CH, NH), 8.10 (s, 2H; NH), 8.41 (s, 8H; NH2),
8.51 (s, 2H; guanidine-NH), 11.69 (s, 2H; guanidine-NH), 12.38 ppm (s,
2H; pyrrole-NH); 13C NMR (100 MHz, [D6]DMSO, 258C): d=38.5
(CH2), 41.0 (CH2), 55.0 (CH), 65.6 (benzyl-CH2), 112.8 (pyrrole-CH),
115.8 (pyrrole-CH), 125.6 (aryl-CH), 127.7 (aryl-CH), 128.3 (aryl-CH),
132.5 (Cq), 136.8 (Cq), 155.4 (Cq), 155.8 (Cq), 159.6 (Cq), 168.9 (Cq),
169.9 ppm (Cq); IR (ATR): n˜ =3061 (brm), 2778 (w), 2359 (w), 1696 (s),
1555 (s), 1255 (s), 1066 cmꢀ1 (m); MALDI: m/z : 857.3 [M+H]+.
(ESI.): m/z: calcd for C20H30N6O8Na: 505.202 [M+Na]+; found 505.202
[M+Na]+, 987.417 [2M+Na]+.
Coupling of 8 with ethylendiamine to the tetra-Boc-protected compound
9: A mixture of the acid 8 (200 mg, 0.42 mmol, 1 equiv), HCTU (191 mg,
0.46 mmol, 1.1 equiv), NMM (138 mL, 1.26 mmol, 3 equiv), and ethylendi-
amine (12 mL, 0.2 mmol, 1/2 equiv) in dichloromethane (20 mL) and
DMF (6 mL) was stirred at room temperature for 40 h. The solvent was
evaporated and the residue taken up in ice water (75 mL). The obtained
white solid was filtered off, washed with water, and lyophilized to yield a
colorless powder (152 mg, 0.15 mmol, 77%). Rf =0.16 (SiO2, dichlorome-
thane/methanol 9:1); m.p. 2158C (decomp); 1H NMR (400 MHz,
[D6]DMSO, 258C): d=1.34 (s, 18H; Boc-CH3), 1.46 (s, 18H; Boc-CH3),
3.09 (s, 4H; EDA-CH2), 3.48–3.51 (m, 4H; CH2), 4.07–4.09 (m, 2H; CH),
6.74–6.77 (m, 6H; pyrrole-CH, Boc-NH), 7.99 (s, 2H; EDA-NH), 8.37 (s,
2H; NH), 8.56 (brs, 2H; guanidine-NH), 9.32 (brs, 2H; guanidine-NH),
10.83 (brs, 2H; guanidine-NH), 11.18 ppm (brs, 2H; pyrrole-NH);
13C NMR (100 MHz, [D6]DMSO, 258C): d=28.1 (Boc-CH3), 38.3 (CH2),
40.8 (CH2), 54.8 (CH), 78.4 (Boc-Cq), 108.0 (pyrrole-CH), 112.0 (pyrrole-
CH), 155.1 (Cq), 158.3 (Cq), 160.2 (Cq), 170.2 ppm (Cq); IR (KBr): n˜ =
3385 (brm), 2979 (m), 2936 (w), 1637 (s), 1547 (s), 1297 (s), 1151 (s),
842 cmꢀ1 (w); HRMS (ESI): m/z: calcd for C42H64N14O14Na: [M+Na]+
1011.462; found 1011.462 [M+Na]+, 889.425 [M+HꢀBoc]+, 789.372
[M+Hꢀ2Boc]+.
Boc-deprotection of 9 to the tetracationic compound 2: A solution of the
Boc-protected compound 9 (140 mg, 0.14 mmol) in TFA (3 mL) was
stirred at room temperature for 2 h. The TFA was evaporated in vacuo,
the obtained residue was dissolved in aqueous solution of HCl (1.5 mL,
5%) and lyophilized to give compound 2 as a colorless solid (100 mg,
Di-Boc-protected methyl ester 7: The Cbz-protected compound 4 (2.15 g,
4.05 mmol) and Pd/C (0.26 g, 10%) were dissolved in methanol (50 mL)
and stirred under hydrogen atmosphere for 2 h at 358C. After complete
reaction (tlc), di-tert-butyldicarbonat (0.97 g, 4.46 mmol, 1.1 equiv) was
added and the reaction mixture was stirred for one additional hour at
358C till the reaction was complete (tlc). The catalyst was filtered off
through a Celite pad and washed thoroughly with methanol. The filtrate
and the combined washing phases were evaporated and lyophilized to
give the methyl ester 7 as a colorless powder (2.01 g, 4.05 mmol, quant.).
Rf =0.48 (SiO2, dichloromethane/methanol 9:1 after Cbz deprotection);
Rf =0.59 (SiO2, dichloromethane/methanol 9:1 after Boc protection);
m.p. 1338C; 1H NMR (400 MHz, [D6]DMSO, 258C): d=1.37 (s, 9H;
Boc-CH3), 1.46 (s, 9H; Boc-CH3), 3.55–3.57 (m, 2H; CH2), 3.61 (s, 3H;
CH3), 4.19–4.21 (m, 1H; CH), 6.75 (s, 1H; pyrrole-CH), 6.80 (s, 1H; pyr-
role-CH), 7.20 (d, 1H; 3J=7.56 Hz, NH), 8.44 (s, 1H; NH), 8.56 (brs,
1H; guanidine-NH), 9.32 (brs, 1H; guanidine-NH), 10.81 (brs, 1H; gua-
nidine-NH), 11.18 ppm (brs, 1H; pyrrole-NH); 13C NMR (100 MHz,
[D6]DMSO, 258C): d=27.8 (Boc-CH3), 28.1 (Boc-CH3), 39.9 (CH2), 51. 9
(CH3), 53.6 (CH), 112.0 (pyrrole-CH), 155.3 (Cq), 158.4 (Cq), 160.3 (Cq),
171.0 ppm (Cq); IR (KBr): n˜ =3388 (brm), 3269 (brm), 2979 (m), 2954
(m), 1726 (s), 1151 (vs), 756 cmꢀ1 (m); HRMS (ESI): m/z: calcd for
C21H32N6O8Na: 519.217 [M+Na]+; found 519.218 [M+Na]+, 1015.451
[2M+Na]+.
1
0.14 mmol, 97%). M.p.>2508C; H NMR (400 MHz, [D6]DMSO, 258C):
d=3.16–3.24 (m, 4H; EDA-CH2), 3.63–3.78 (m, 4H; CH2), 3.95 (d, 2H;
3J=5.52 Hz, CH), 6.95 (d, 2H; 3J=1.88 Hz, pyrrole-CH), 7.53 (d, 2H;
3J=1.76 Hz, pyrrole-CH), 8.40 (s, 8H; NH2), 8.61 (brs, 6H; NH3+), 8.82–
8.84 (m, 4H; amide-NH), 12.03 (s, 2H; guanidine-NH), 12.38 ppm (s,
2H; pyrrole-NH); 13C NMR (100 MHz, [D6]DMSO, 258C): d=38.3
(CH2), 39.5 (CH2), 52.4 (CH), 108.0 (pyrrole-CH), 113.1 (pyrrole-CH),
125.7 (pyrrole-Cq), 132.2 (Cq), 155.5 (Cq), 159.6 (Cq), 160.0 (Cq),
166.8 ppm (Cq); IR (KBr): n˜ =3325 (brm), 3209 (brm), 3098 (brm), 2971
(brm), 2869 (brm), 1699 (s), 1557 (m), 1283 (m), 1200 (m), 754 cmꢀ1 (w);
HRMS (ESI): m/z: calcd for C22H33N14O8: 589.270 [M]+; found 589.273
[M]+.
Boc-protection of the secondary amine of the Cbz- and Boc-protected
methyl ester 10: Triethylamine (0.14 mL, 1.46 mmol, 1.5 equiv) was
added to a solution of the methyl ester 10 (500 mg, 0.97 mmol, 1 equiv)
in methanol (30 mL). Under vigorously stirring a solution of di-tert-butyl-
dicarbonat (230 mg, 1.06 mmol, 1.1 equiv) in methanol (10 mL) was
added dropwise, and the resulting suspension was stirred for 18 h at room
temperature. Afterwards the solvent was evaporated. By adding water a
white solid precipitated. The solid was filtered off, washed with ice water,
and lyophilized giving the desired product 11 (567 mg, 0.92 mmol, 94%)
as a colorless powder. Rf =0.76 (SiO2, dichloromethane/methanol 9:1);
m.p. 1048C; 1H NMR (400 MHz, [D6]DMSO, 258C): d=1.37 (s, 9H;
Boc-CH3), 1.46 (s, 9H; Boc-CH3), 3.57–3.61 (m, 2H; CH2), 3.63 (s, 3H;
CH3), 4.26–4.45 (m, 3H; CH, CH2), 5.04 (s, 2H; benzyl-CH2), 6.02 (s,
1H; pyrrole-CH), 7.10 (brs, 1H; pyrrole-CH), 7.32–7.35 (m, 5H; aryl-
CH), 7.72 (s, 1H; Cbz-NH), 8.33 (brs, 1H; guanidine-NH), 9.41 (brs,
1H; guanidine-NH), 11.30 (brs, 1H; guanidine-NH), 11.72 ppm (brs,
1H; pyrrole-NH); 13C NMR (100 MHz, [D6]DMSO, 258C): d=27.8
(Boc-CH3), 27.9 (Boc-CH3), 31.3 (CH3), 45.6 (CH2), 47.0 (CH2), 52.1
(CH), 65.7 (benzyl-CH2), 79.6 (Boc-Cq), 108.3 (pyrrole-CH), 127.7 (aryl-
CH), 127.8 (aryl-CH), 128.3 (aryl-CH), 136.8 (aryl-Cq), 156.0 (Cq),
171.9 ppm (Cq); IR (KBr): n˜ =3382 (brm), 2977 (m), 1728 (s), 1698 (s),
1153 (s), 1057 (m), 843 cmꢀ1 (w); HRMS (ESI): m/z: calcd for
C29H41N6O9: 617.293 [M]+; found 617.294 [M]+, 517.237 [MꢀBoc]+.
Di-Boc-protected acid 8: Lithium hydroxide (182 mg, 7.40 mmol,
1.5 equiv) was added to a solution of methyl ester 7 (2.00 g, 4.03 mmol,
1 equiv) in THF/water (20 mL, 4.1). The resulting solution was stirred for
4 h at room temperature. After complete reaction (tlc) the solvent was
evaporated and the resulting residue was dissolved in water. By adding
aqueous solution of HCl (5%) till a pH of 5–6 was reached a white solid
precipitates. The solid was filtered off, washed with ice water, and was
dried by lyophilization to give the acid 8 (1.10 g, 2.28 mmol, 57%) as a
colorless solid. Rf =0.20 (SiO2, dichloromethane/methanol 9:1); m.p.
2368C (decomp); 1H NMR (400 MHz, [D6]DMSO, 258C): d=1.37 (s,
9H; Boc-CH3), 1.46 (s, 9H; Boc-CH3), 3.50–3.57 (m, 2H; CH2), 4.09–4.11
(m, 1H; CH), 6.74 (s, 1H; pyrrole-CH), 6.81 (s, 1H; pyrrole-CH), 6.97
(d, 1H; 3J=7.84 Hz, NH), 8.43 (s, 1H; NH), 8.56 (brs, 1H; guanidine-
NH), 9.32 (brs, 1H; guanidine-NH), 10.81 (brs, 1H; guanidine-NH),
11.16 ppm (brs, 1H; pyrrole-NH); 13C NMR (100 MHz, [D6]DMSO,
258C): d=27.8 (Boc-CH3), 28.1 (Boc-CH3), 40.3 (CH2), 53.8 (CH), 78.2
(Boc-Cq), 112.0 (pyrrole-CH), 155.3 (Cq), 158.4 (Cq), 160.1 (Cq),
172.4 ppm (Cq); IR (KBr): n˜ =3371 (brm), 2979 (m), 2936 (w), 1695 (s),
1631 (s), 1557 (s), 1294 (s), 1151 (s), 841 (w), 758 cmꢀ1 (w); HRMS
Cbz- and di-Boc-protected acid 12: Lithium hydroxide (30 mg,
1.22 mmol, 1.5 equiv) was added to a solution of the methyl ester 11
(500 mg, 0.81 mmol, 1 equiv) in THF/water (10 mL, 4:1). The resulting
solution was stirred at room temperature for 5 h. After complete reaction
(tlc) the solvent was evaporated, the resulting residue was dissolved in
Chem. Eur. J. 2012, 18, 1352 – 1363
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1361